Publication | Open Access

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

VaccinationVaccine SafetyTwo-dose Heterologous Ad26.zebovEmerging Infectious DiseasesVaccine TestingVaccine EfficacySierra LeoneInfection ControlVaccine HesitancyMedicineVaccine ResearchEpidemiology